Accueil/Actions/TARS

TARS

USD

Tarsus Pharmaceuticals Inc. Common Stock

$68.250+0.440 (0.649%)

Prix en Temps Réel

Healthcare

Biotechnologie

États-Unis

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché

Fondamentaux de l'Entreprise

Statistiques de Trading

Métriques de Marché

Ouverture

$67.810

Haut

$69.250

Bas

$65.935

Volume

0.95M

Fondamentaux de l'Entreprise

Capitalisation Boursière

2.9B

Industrie

Biotechnologie

Pays

United States

Statistiques de Trading

Volume Moyen

0.65M

Bourse

NMS

Devise

USD

Intervalle sur 52 Semaines

Bas $38.51Actuel $68.250Haut $76.81

Actualités Connexes

4 nov. 2025 · 21:05

GlobeNewswire

Tarsus Reports Third Quarter 2025 Financial Results and Recent Business Achievements

Delivered quarterly XDEMVY® net sales of approximately $119 million, up approximately 147% year-over-year Weekly multi-patient prescribers grew approximately 30% in the third quarter underscoring strong commercial

Tarsus Reports Third Quarter 2025 Financial Results and Recent Business Achievements

28 oct. 2025 · 21:00

GlobeNewswire

Tarsus to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025

IRVINE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS), today announced that it will host a live webcast at 1:30 p.m. PT / 4:30 p.m. ET on Tuesday, November 4, 2025 to report its